A Small-Molecule CD4-Mimetic Compound Protects Bone Marrow-Liver-Thymus Humanized Mice From HIV-1 Infection.
J Infect Dis
; 218(3): 471-475, 2018 07 02.
Article
in En
| MEDLINE
| ID: mdl-29617845
ABSTRACT
Background:
Small-molecule CD4-mimetic compounds (CD4mc) inhibit human immunodeficiency virus (HIV-1) entry by blocking binding to the CD4 receptor and by premature triggering of the viral envelope glycoprotein (Env) spike.Methods:
The efficacy of a CD4mc in protecting bone marrow-liver-thymus (BLT) humanized mice from vaginal HIV-1 challenge was evaluated.Results:
Intravaginal application of the CD4mc JP-III-48, either before or simultaneously with virus challenge, protected BLT humanized mice from HIV-1JR-CSF infection in a dose- dependent manner.Conclusion:
The direct antiviral effects of a CD4mc prevent HIV-1 infection in a murine model of sexual transmission.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
CD4 Antigens
/
HIV Infections
/
HIV-1
/
HIV Fusion Inhibitors
/
Biomimetics
Limits:
Animals
Language:
En
Journal:
J Infect Dis
Year:
2018
Type:
Article